AC
Argentiere Capital Portfolio holdings
AUM $1.33M
1-Year Return
3.71%
This Quarter Return
+2.48%
1 Year Return
-3.71%
3 Year Return
+5.98%
5 Year Return
+14.32%
10 Year Return
–
AUM
$208M
AUM Growth
+$22.6M
(+12%)
Cap. Flow
+$12.3M
Cap. Flow
% of AUM
5.9%
Top 10 Holdings %
Top 10 Hldgs %
62.77%
Holding
69
New
20
Increased
8
Reduced
10
Closed
16
Top Buys
| 1 |
TWX
Time Warner Inc
TWX
|
+$21M |
| 2 |
MON
Monsanto Co
MON
|
+$19.2M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$19M |
| 4 |
iShares MSCI South Africa ETF
EZA
|
+$14.7M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$13.1M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$67.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$7.06M |
| 3 |
Medtronic
MDT
|
+$6.41M |
| 4 |
Salesforce
CRM
|
+$6.27M |
| 5 |
JPMorgan Chase
JPM
|
+$6.18M |
Sector Composition
| 1 | Healthcare | 13.4% |
| 2 | Communication Services | 10.77% |
| 3 | Technology | 10.02% |
| 4 | Energy | 9.52% |
| 5 | Financials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWX
1
DELISTED
Time Warner Inc
TWX
| $21M | 8.43% |
+215,000
| New | +$21M |
|
|
MON
2
DELISTED
Monsanto Co
MON
| $19.2M | 7.73% |
+170,000
| New | +$19.2M |
|
|
3
Financial Select Sector SPDR Fund
XLF
$53.9B
| $19M | 7.62% |
+800,000
| New | +$19M |
|
|
4
iShares MSCI South Africa ETF
EZA
$445M
| $14.7M | 5.92% |
+267,200
| New | +$14.7M |
|
|
RAI
5
DELISTED
Reynolds American Inc
RAI
| $13.1M | 5.27% |
+208,249
| New | +$13.1M |
|
6
NXP Semiconductors
NXPI
$55.5B
| $11.4M | 4.57% |
110,000
+40,000
| +57% | +$4.14M |
|
7
United Therapeutics
UTHR
$18.2B
| $10.7M | 4.31% |
+79,367
| New | +$10.7M |
|
|
8
iShares MSCI Emerging Markets ETF
EEM
$20.1B
| $8.17M | 3.28% |
207,300
-179,100
| -46% | -$7.06M |
|
|
9
JPMorgan Chase
JPM
$845B
| $7.34M | 2.95% |
83,500
-70,300
| -46% | -$6.18M |
|
10
Halliburton
HAL
$18.6B
| $5.98M | 2.4% |
+121,538
| New | +$5.98M |
|
11
WisdomTree India Earnings Fund ETF
EPI
$2.89B
| $5.07M | 2.03% |
+210,000
| New | +$5.07M |
|
12
Bristol-Myers Squibb
BMY
$94.6B
| $4.78M | 1.92% |
+87,880
| New | +$4.78M |
|
13
Gilead Sciences
GILD
$140B
| $3.74M | 1.5% |
55,000
-20,192
| -27% | -$1.37M |
|
14
BioMarin Pharmaceuticals
BMRN
$10.3B
| $3.6M | 1.45% |
41,000
+10,000
| +32% | +$878K |
|
15
Nabors Industries
NBR
$609M
| $3.59M | 1.44% |
5,500
+3,700
| +206% | +$2.42M |
|
16
Citigroup
C
$184B
| $3.58M | 1.44% |
59,800
-61,200
| -51% | -$3.66M |
|
|
APC
17
DELISTED
Anadarko Petroleum
APC
| $3.41M | 1.37% |
+55,000
| New | +$3.41M |
|
18
GE Aerospace
GE
$307B
| $3.35M | 1.34% |
23,442
+10,234
| +77% | +$1.46M |
|
|
XEC
19
DELISTED
CIMAREX ENERGY CO
XEC
| $3.35M | 1.34% |
28,000
+14,741
| +111% | +$1.76M |
|
20
Goldman Sachs
GS
$238B
| $3.1M | 1.25% |
+13,500
| New | +$3.1M |
|
|
AGN
21
DELISTED
Allergan plc
AGN
| $3.05M | 1.22% |
12,757
-281,620
| -96% | -$67.3M |
|
22
Exxon Mobil
XOM
$481B
| $3.02M | 1.21% |
+36,870
| New | +$3.02M |
|
23
Delta Air Lines
DAL
$37.6B
| $2.99M | 1.2% |
65,000
+20,975
| +48% | +$964K |
|
24
Corpay
CPAY
$21.5B
| $2.94M | 1.18% |
+19,400
| New | +$2.94M |
|
25
Intel
INTC
$117B
| $2.93M | 1.18% |
81,246
+13,117
| +19% | +$473K |
|